The protective effects of selenium against NLRP3-mediated inflammation and pyroptosis: mechanisms and the potential health benefits

Selenium (Se) is an essential metalloid, possessing not only antioxidant but also anti-inflammatory effects. Recent studies have shown that the latter may be mediated by modulation of NLRP3 inflammasome activation, although the exact mechanisms have yet to be fully characterized. Therefore, the objective of this review is to discuss the molecular mechanisms by which Se modulates NLRP3 inflammasome activation and to examine the downstream effects on NLRP3-mediated inflammation and pyroptotic cell death. The selenoproteins S, O, M, W, and especially glutathione peroxidase (GPX) and thioredoxin reductase (TXNRD) are involved in regulation of the NLRP3 inflammasome machinery through modulation of redox homeostasis. In contrast, Se deficiency has been shown to aggravate NLRP3 inflammasome activation induced by lipopolysaccharide (LPS) treatment or exposure to organic pollutant bisphenol A (BPA). In addition to increased reactive oxygen species (ROS) generation, Se deficiency contributes to NLRP3-mediated inflammation and pyroptosis through modulation of non-coding RNA expression. In turn, Se supplementation mitigates NLRP3 inflammasome activation in liver, heart, kidneys, intestine, brain, and certain other tissues induced by LPS exposure, ischemia/reperfusion (I/R), and various xenobiotics including heavy metals and organic pollutants. This effect appears to be mediated by modulation of various components of Toll-like receptor (TLR)/nuclear factor κB (NF-κB)/NRLP3, nuclear factor erythroid 2-related factor 2 (Nrf2)/ROS/NLRP3, thioredoxin-interacting protein (TXNIP)/NLRP3 pathways, and several other mechanisms including modulation of gut microbiota with subsequent reduction of circulating LPS levels. Collectively, these findings demonstrate that the anti-inflammatory and cytoprotective effects of Se supplementation may be mediated by modulation of NLRP3 inflammasome activation. © 2025 Elsevier B.V., All rights reserved.

Авторы
Skalny Andrey A. 1, 2 , Áschner Michael 3 , Santamaría Abel 4 , Alekseenko Svetlana I. 5, 6 , Lu Rongzhu 7 , Rocha Joao Batista Teixeira Da 8, 12 , Nekhorosheva A.V. 9 , Gritsenko Viktor A. 10 , Tinkov Alexey A. 1, 10, 11
Журнал
Издательство
Springer Science+Business Media B.V., Formerly Kluwer Academic Publishers B.V.
Язык
Английский
Статус
Опубликовано
Год
2025
Организации
  • 1 Center of Bioelementology and Human Ecology, Sechenov First Moscow State Medical University, Moscow, Russian Federation
  • 2 Department of Medical Elementology, RUDN University, Moscow, Russian Federation
  • 3 Department of Molecular Pharmacology, Albert Einstein College of Medicine, New York, United States
  • 4 Universidad Autónoma Metropolitana Unidad Xochimilco, Mexico, Mexico
  • 5 Saint-Petersburg Institute of Ear, Nose, Throat, and Speech, Saint Petersburg, Russian Federation
  • 6 K.A. Raukhfus Children's City Multidisciplinary Clinical Center for High Medical Technologies, Saint Petersburg, Russian Federation
  • 7 Department of Preventive Medicine and Public Health Laboratory Science, Jiangsu University, Zhenjiang, China
  • 8 Department of Biochemistry and Molecular Biology, Universidade Federal de Santa Maria, Santa Maria, Brazil
  • 9 Khanty-Mansiysk State Medical Academy, Khanty-Mansiysk, Russian Federation
  • 10 Institute for Cellular and Intracellular Symbiosis of the Ural Branch of the Russian Academy of Sciences, Orenburg, Russian Federation
  • 11 Laboratory of Ecobiomonitoring and Quality Control, Yaroslavl State University, Yaroslavl, Russian Federation
  • 12 Department of Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
Ключевые слова
Cytotoxicity; Inflammation; Selenium; Selenium deficiency; Selenoproteins
Цитировать
Поделиться

Другие записи

Аватков В.А., Апанович М.Ю., Борзова А.Ю., Бордачев Т.В., Винокуров В.И., Волохов В.И., Воробьев С.В., Гуменский А.В., Иванченко В.С., Каширина Т.В., Матвеев О.В., Окунев И.Ю., Поплетеева Г.А., Сапронова М.А., Свешникова Ю.В., Фененко А.В., Феофанов К.А., Цветов П.Ю., Школярская Т.И., Штоль В.В. ...
Общество с ограниченной ответственностью Издательско-торговая корпорация "Дашков и К". 2018. 411 с.